Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.310
0.00 (0.00%)
Aug 13, 2025, 4:00 PM - Market closed
Standard BioTools Employees
As of December 31, 2024, Standard BioTools had 818 total employees, including 814 full-time and 4 part-time employees. The number of employees increased by 279 or 51.76% compared to the previous year.
Employees
818
Change (1Y)
279
Growth (1Y)
51.76%
Revenue / Employee
$210,600
Profits / Employee
-$147,313
Market Cap
497.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LAB News
- 2 days ago - Standard BioTools Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 8 days ago - Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study - GlobeNewsWire
- 24 days ago - Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025 - GlobeNewsWire
- 7 weeks ago - Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy - PRNewsWire
- 7 weeks ago - Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina - GlobeNewsWire
- 2 months ago - Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series - GlobeNewsWire
- 3 months ago - Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 3 months ago - Standard BioTools Reports First Quarter 2025 Financial Results - GlobeNewsWire